CognitMarket market news, portfolio research, and investor insights

GIC Private Ltd, a significant shareholder and director of Medline Inc. (MDLN), disposed of 7.82 million Class A Common Stock shares on Oct 8 for $274.77 million . The sale, at $35.15 per share, comes as MDLN shares have declined 24.5% over the past six months. GIC Private Ltd remains a major holder with 16.45 million direct shares and 69.41 million indirect shares .

The Philadelphia Semiconductor Index (SOX) recorded its longest losing streak since 2008, falling for eight consecutive sessions and dropping 16% since October 6th . The selloff, which saw all 30 constituents decline, is driven by growing investor concerns over AI spending sustainability, rising financing costs, and elevated valuations .

Key points:

• SOX index fell 3.83% on Friday, extending losses to 8 sessions.
• Individual stocks like AVGO, MU, AMD, INTC, LRCX, KLAC, and ARM dropped around 5-7% .
• CoreWeave (CRWV) shares slumped 12%, with bond yields surging above 15% .
• Hotter-than-expected US inflation is increasing the cost of capital for AI infrastructure investments .

This signals a significant shift in sentiment for the previously booming AI chip sector.

Moderna (MRNA) President Stephen Hoge sold approximately $17.01 million worth of company stock on October 14-15, following option exercises. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan .

Key details:

• Sale Value: $17.01 million
• Shares Sold: 78,369 shares at weighted average prices between $213.47 and $220.72
• Option Exercise: Hoge also acquired 152,905 shares via option exercises at $12.21 per share
• Context: MRNA stock has returned 738% over the past year and is currently trading at $218.01. InvestingPro analysis suggests the stock appears overvalued relative to its Fair Value .

Global hedge funds suffered steep losses this week, primarily driven by a sharp unwind of crowded AI bets. Long-short funds lost 2.9% for the week, with Asia-focused managers down 2.6% and tech-focused funds off 2.0% on Thursday alone . Goldman Sachs reports six consecutive sessions of AI stock selling by long-short fund managers .

This institutional selling pressure, coupled with rising borrowing costs and investor questions about AI spending ROI, signals a deepening correction in the AI sector. CoreWeave bonds have sold off sharply, pushing yields above 15% .

Key points:

• Hedge Fund Losses: Global long-short funds down 2.9% this week .
• AI Stock Selling: Six straight sessions of net selling by long-short managers .
• Crowded Trade Unwind: Reflects a 'macro reality check' rather than fundamental rejection of AI .

This development reinforces recent market alerts regarding the AI/semiconductor sector sell-off and rotation out of tech .

SoftBank Group is reportedly considering a $30 billion acquisition of Allied Universal, the largest security services company in the US . The potential deal, valued at up to $18 billion in equity plus $12 billion in debt, would provide SoftBank founder Masayoshi Son with a vast workforce and customer base to deploy AI-powered robots . This move highlights Son's ambition to integrate AI into physical-world operations, with security identified as a key area for robotics deployment. Discussions are preliminary, but the transaction could significantly impact the security and robotics sectors .

The U.S. fiscal year 2026 concluded with a budget deficit of nearly $2 trillion ($1.992T), marking a 12% increase from the prior year. This is the third-highest annual deficit in U.S. history, excluding pandemic stimulus years.

Key figures:

• Total Deficit: $1.992 trillion (vs. $1.775T in FY2025)
• Spending Drivers: Social Security ($1.7T), Medicare ($1.1T), and net interest payments (over $1T) were major contributors.
• Revenue: Individual income taxes rose 7% to over $2.8T, while corporate income tax receipts fell by $70B .

The persistent deficit adds to concerns over the nation's financial health, previously reflected in rising Treasury yields.

Eli Lilly's oral weight-loss drug, Foundayo, has received a recommendation for approval from the European Medicines Agency (EMA). This marks the second oral obesity drug to gain EU backing, following Novo Nordisk's Wegovy pill .

Key points:

• EMA's committee recommended Foundayo for weight management and type 2 diabetes in adults .
• Patients in trials lost up to 11% of body weight .
• Foundayo is already launched in the US (April) and UK (August), generating $98M in Q2 sales .
• Lilly touts Foundayo's convenience, as it can be taken without food/water restrictions, unlike Wegovy .

This approval positions Lilly to compete in a market projected to exceed $100 billion by 2030, intensifying the race with Novo Nordisk for market share .

Fox Factory Holding Corp. (FOXF) announced a leadership change and significantly lowered its fiscal 2026 outlook after preliminary Q3 results fell short of guidance.

Key points:

• CEO Mike Dennison stepped down, replaced by interim CEO Douglas Grimm .
• Q3 net sales expected at $336M-$340M, below guidance of $355M-$380M.
• Adjusted EBITDA projected at $38M-$42M, missing guidance of $46M-$54M.
• Full FY26 net sales guidance cut to $1.35B-$1.38B (from $1.42B-$1.47B).
• Full FY26 adjusted EBITDA guidance slashed to $140M-$150M (from $176M-$196M).

The company cited lower sales/margins at Marucci Sports, supply disruptions, operational challenges, and softer bike sales for the shortfall .

Tesla shares surged nearly 5% in premarket trading after CEO Elon Musk unveiled the new Roadster model with a live demonstration, targeting 2028 production . This comes as broader AI trade concerns continue, with 'neocloud' company CoreWeave's debt showing distress . The S&P 500 and Nasdaq Composite are still on track for weekly declines .

The White House reportedly directed SpaceX to restrict its Starshield satellite service for Ukraine's military, impacting battlefield communications and drone operations . This move comes amidst President Trump's push for Kyiv to halt strikes on Russian refineries and a diesel supply deal with Russia, raising questions about U.S. policy and potential geopolitical shifts. The Pentagon is Starshield's largest customer .